CELADON PHARMACEUTICALS PLC — Director's Dealing 2021

Apr 9, 2021

National Storage Mechanism | Additional information

RNS Number : 9960U

Summerway Capital PLC

09 April 2021

9 April 2021

Summerway Capital Plc

("Summerway" or the "Company")

Director / PDMR Dealing

Summerway Capital Plc announces that on 8 April 2021 it was notified that Vin Murria OBE, Chairman of the Company, sold 1,000,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to a leading UK institutional equity investor, at a price of 165 pence per Ordinary Share.

Following this transaction, Ms Murria's total beneficial interest in the Company is 1,403,409 Ordinary Shares representing approximately 17.5 per cent. of the Company's total issued share capital. 

The Notification of Dealing Form required in accordance with Article 19.3 of MAR is set out below.

a)

Name

Vin Murria

2

Reason for the notification

a)

Position/status

Chair

b)

Initial notification / Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Summerway Capital plc

b)

LEI

213800YXCATORT475807

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

GB00BDQYGP38

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
165 pence per share	1,000,000

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

7 April 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Enquiries:

Summerway Capital Plc

Tony Morris (Director)                                                                                   +44 (0) 20 7440 7520

N+1 Singer (Nominated Adviser and Broker)

Sandy Fraser, Amanda Gray                                                                        +44 (0) 20 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSAFSUEFSEEL